Andean Precious Metals Corp. (CVE:APM – Free Report) – Research analysts at Desjardins issued their Q2 2024 earnings per share (EPS) estimates for shares of Andean Precious Metals in a research report issued to clients and investors on Sunday, July 21st. Desjardins analyst J. Sclodnick anticipates that the company will post earnings per share of $0.08 for the quarter. Desjardins has a “Moderate Buy” rating on the stock.
Andean Precious Metals Trading Down 3.7 %
CVE:APM opened at C$1.04 on Tuesday. Andean Precious Metals has a fifty-two week low of C$0.53 and a fifty-two week high of C$1.10. The firm’s 50-day simple moving average is C$0.99. The stock has a market cap of C$157.42 million, a PE ratio of 3.47 and a beta of 0.98.
Insider Activity
Andean Precious Metals Company Profile
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
See Also
- Five stocks we like better than Andean Precious Metals
- Manufacturing Stocks Investing
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- EV Stocks and How to Profit from Them
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- 5 Top Rated Dividend Stocks to Consider
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.